Aurigene Pharmaceutical Services Profile
Key Indicators
- Authorised Capital ₹ 170.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 156.12 Cr
as on 24-10-2024
- Company Age 5 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -7.59%
(FY 2023)
- Profit -60.33%
(FY 2023)
- Ebitda -28.69%
(FY 2023)
- Net Worth 3.66%
(FY 2023)
- Total Assets -5.88%
(FY 2023)
About Aurigene Pharmaceutical Services
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 170.00 Cr and a paid-up capital of Rs 156.12 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Aurigene Pharmaceutical Services Limited India are Akhil Ravi as CEO and Atul Sachdeva as Cfo. Venkatanarasimham Mannam, Jesal Baldev, Erez Israeli, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999KA2019PLC127964
- Company No.
127964
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
16 Sep 2019
- Date of AGM
26 Jul 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Aurigene Pharmaceutical Services?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Akhil Ravi | CEO | 01-Feb-2022 | Current |
| Atul Sachdeva | CFO | 27-Jul-2022 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkatanarasimham Mannam  | Director | 16-Sep-2019 | Current |
| Jesal Baldev | Director | 16-Apr-2024 | Current |
| Erez Israeli | Director | 16-Sep-2019 | Current |
| Deepak Sapra | Director | 16-Sep-2019 | Current |
Financial Performance and Corporate Structure Insights of Aurigene Pharmaceutical Services.
Aurigene Pharmaceutical Services Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 7.59% decrease. The company also saw a substantial fall in profitability, with a 60.33% decrease in profit. The company's net worth moved up by a moderate rise of 3.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aurigene Pharmaceutical Services?
In 2023, Aurigene Pharmaceutical Services had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Idea2enterprises (India) Private LimitedActive 24 years 6 monthsVenkatanarasimham Mannam is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aurigene Pharmaceutical Services?
Aurigene Pharmaceutical Services has a workforce of 906 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aurigene Pharmaceutical Services, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aurigene Pharmaceutical Services's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
